Critical illness myopathy

Current Opinion in Rheumatology

Volumn 24, Issue 6, 2012, Pages 616-622

  Latronico, Nicola ^a   Tomelleri, Giuliano ^b   Filosto, Massimiliano ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

acute myopathy; chronic disability; mechanical ventilation; muscle weakness; myosin

Indexed keywords

ASCORBIC ACID; MYOSIN; NITRIC OXIDE DONOR; PYRIDOSTIGMINE;

BRAIN ELECTROPHYSIOLOGY; CRITICAL ILLNESS; CRITICAL ILLNESS MYOPATHY; CRITICAL ILLNESS POLYNEUROPATHY; HUMAN; INCIDENCE; MUSCLE BIOPSY; NEUROMUSCULAR DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; STEROID THERAPY;

ACUTE DISEASE; COMORBIDITY; ELECTROPHYSIOLOGY; HUMANS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOSITIS; NECROSIS; POLYNEUROPATHIES;

EID: 84867016788     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283588d2f     Document Type: Review

References (75)

1. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10:931-941.
2. Baue AE. Multiple, progressive, or sequential systems failure: a syndrome of the 1970s. Arch Surg 1975; 110:779-781.
3. Latronico N, Candiani A. Muscular wasting as a consequence of sepsis. In Gullo A, editor. Anaesthesia, pain, intensive care and emergency medicine, APICE. 13th ed. Milan: Springer-Verlag; 1998. pp. 517-522.
4. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 2000; 23:1785-1788.
5. Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 2009; 37 (Suppl):299-308.
6. Bolton CF. The discovery of critical illness polyneuropathy: a memoir. Can J Neurol Sci 2010; 37:431-438.
7. Latronico N, Bertolini G, Guarneri B, et al. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multicentre CRIMYNE study. Crit Care 2007; 11:R11.
8. Latronico N, Fenzi F, Recupero D, et al. Critical illness myopathy and neuropathy. Lancet 1996; 347:1579-1582. (Pubitemid 26170874)
9. Koch S, Spuler S, Deja M, et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 2011; 82:287-293.
10. Lefaucheur JP, Nordine T, Rodriguez P, Brochard L. Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 2006; 77:500-506.
11. Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 2003; 29:1505-1514. (Pubitemid 37153595)
12. Stevens RD, Dowdy DW, Michaels RK, et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007; 33:1876-1891. (Pubitemid 47632264)
13. Tennila A, Salmi T, Pettila V, et al. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000; 26:1360-1363.
14. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: critical illness polyneuropathy and myopathy. Crit Care 2008; 12:238.
15. Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 2008; 197:1-10. (Pubitemid 351566920)
16. Fitts RH, Romatowski JG, Peters JR, et al. The deleterious effects of bed rest on human skeletal muscle fibers are exacerbated by hypercortisolemia and ameliorated by dietary supplementation. Am J Physiol Cell Physiol 2007; 293:C313-C320. (Pubitemid 47105022)
17. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-693. (Pubitemid 36237037)
18. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175:480-489. (Pubitemid 46354252)
19. Derde S, Hermans G, Derese I, et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Critical Care Med 2012; 40:79-89.
20. Puthucheary Z, Rawal J, Ratnayake G, et al. Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence? Am J Respir Crit Care Med 2012; 185:911-917.
21. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99:176-184.
22. Lightfoot A, McArdle A, Griffiths RD. Muscle in defense. Crit Care Med 2009; 37:S384-S390.
23. Jaber S, Petrof BJ, Jung B, et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med 2011; 183:364-371.
24. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-1477. (Pubitemid 30318270)
25. Vasilevskis EE, Ely EW, Speroff T, et al. Reducing iatrogenic risks: ICUacquired delirium and weakness-crossing the quality chasm. Chest 2010; 138:1224-1233.
26. Pandharipande P, Cotton BA, Shintani A, et al. Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 2007; 33:1726-1731. (Pubitemid 47476638)
27. Friedrich O. Critical illness myopathy: what is happening? Curr Opin Clin Nutr Metab Care 2006; 9:403-409. (Pubitemid 44097810)
28. Ochala J, Renaud G, Llano Diez M, et al. Diaphragm muscle weakness in an experimental porcine intensive care unit model. PLoS One 2011; 6:e20558.
29. Files DC, D'Alessio FR, Johnston LF, et al. A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. Am J Respir Crit Care Med 2012; 185:825-834.
30. McClung JM, Kavazis AN, DeRuisseau KC, et al. Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy. Am J Respir Crit Care Med 2007; 175:150-159. (Pubitemid 46115086)
31. Nelson WB, Smuder AJ, Hudson MB, et al. Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation. Crit Care Med 2012; 40:1857-1863.
32. Kortebein P, Ferrando A, Lombeida J, et al. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. J Am Med Assoc 2007; 297:1772-1774. (Pubitemid 46658661)
33. Truong AD, Fan E, Brower RG, Needham DM. Bench-to-bedside review: mobilizing patients in the intensive care unit-from pathophysiology to clinical trials. Crit Care 2009; 13:216.
34. Ochala J, Gustafson AM, Diez ML, et al. Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms. J Physiol 2011; 589:2007-2026.
35. Horinouchi H, Kumamoto T, Kimura N, et al. Myosin loss in denervated rat soleus muscle after dexamethasone treatment. Pathobiology 2005; 72:108-116. (Pubitemid 40674993)
36. Massa R, Carpenter S, Holland P, Karpati G. Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation. Muscle Nerve 1992; 15:1290-1298.
37. Helliwell TR, Wilkinson A, Griffiths RD, et al. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 1998; 24:507-517. (Pubitemid 29002282)
38. Vattemi G, Tonin P, Filosto M, et al. Reversible upper limb muscle weakness with selective loss of thick filaments. Neurology 2003; 61:863-864. (Pubitemid 37174496)
39. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004; 364:545-548. (Pubitemid 39070417)
40. Vanhorebeek I, Langouche L, Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005; 11:304-311. (Pubitemid 41248301)
41. Van den Berghe G, Schoonheydt K, Becx P, et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-1353. (Pubitemid 40570499)
42. Bertolini G, Latronico N, Brazzi L, Radrizzani D. Insulin dose or glycemic control for the critically ill? Crit Care Med 2003; 31:2565-2566; author reply 6. (Pubitemid 37281752)
43. Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831. (Pubitemid 39202356)
44. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005; 9 (Suppl 4): S13-S19. (Pubitemid 41498527)
45. Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Investig 1994; 94:2077-2083. (Pubitemid 24348249)
46. De Backer D, Ospina-Tascon G, Salgado D, et al. Monitoring the microcirculation in the critically ill patient: current methods and future approaches. Intensive Care Med 2010; 36:1813-1825.
47. Secor D, Li F, Ellis CG, et al. Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med 2010; 36:1928-1934.
48. Balestra GM, Legrand M, Ince C. Microcirculation and mitochondria in sepsis: getting out of breath. Curr Opin Anaesthesiol 2009; 22:184-190.
49. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223. (Pubitemid 34804650)
50. Azevedo LC. Mitochondrial dysfunction during sepsis. Endocrine Metab Immune Disord Drug Targets 2010; 10:214-223.
51. Haden DW, Suliman HB, Carraway MS, et al. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med 2007; 176:768-777. (Pubitemid 47598478)
52. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998; 43:171-179. (Pubitemid 28110119)
53. Khan J, Harrison TB, Rich MM. Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin 2008; 24:165-177. (Pubitemid 351172686)
54. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. J Am Med Assoc 2002; 288:2859-2867. (Pubitemid 35425072)
55. Ali NA, O'Brien JM Jr, Hoffmann SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008; 178:261-268.
56. Hermans G, Clerckx B, Vanhullebusch T, et al. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve 2012; 45:18-25.
57. Hough CL, Lieu BK, Caldwell ES. Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care 2011; 15:R43.
58. De Jonghe B, Bastuji-Garin S, Sharshar T, et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 2004; 30:1117-1121. (Pubitemid 38833364)
59. Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL, et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005; 33:349-354. (Pubitemid 40216548)
60. Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 2008; 79:838-841.
61. Bierbrauer J, Koch S, Olbricht C, et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Critical care medicine 2012; 40:647-650.
62. Stibler H, Edstrom L, Ahlbeck K, et al. Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 2003; 29:1515-1527. (Pubitemid 37153596)
63. Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Critical Care Med 2012; 40:502-509.
64. Herridge MS, Tansey CM, Matte A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364:1293-1304.
65. Angel MJ, Bril V, Shannon P, Herridge MS. Neuromuscular function in survivors of the acute respiratory distress syndrome. Can J Neurol Sci 2007; 34:427-432. (Pubitemid 350248270)
66. Orford NR, Saunders K, Merriman E, et al. Skeletal morbidity among survivors of critical illness. Crit Care Med 2011; 39:1295-1300.
67. Latronico N, Shehu I, Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care 2005; 11:381-390. (Pubitemid 41248314)
68. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998; 21:610-617. (Pubitemid 28185889)
69. Intiso D, Amoruso L, Zarrelli M, et al. Long-term functional outcome and health status of patients with critical illness polyneuromyopathy. Acta Neurol Scand 2011; 123:211-219.
70. Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003; 31:1012-1016. (Pubitemid 36444406)
71. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
72. Routsi C, Gerovasili V, Vasileiadis I, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care 2010; 14:R74.
73. Poulsen JB, Moller K, Jensen CV, et al. Effect of transcutaneous electrical muscle stimulation on muscle volume in patients with septic shock. Crit Care Med 2011; 39:456-461.
74. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009; 373:1874-1882.
75. Frick CG, Helming M, Martyn JA, et al. Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. Crit Care Med 2010; 38:922-927.